Ignite Creation Date:
2025-12-25 @ 3:30 AM
Ignite Modification Date:
2026-01-12 @ 11:45 AM
Study NCT ID:
NCT03849105
Status:
COMPLETED
Last Update Posted:
2023-04-14
First Post:
2019-01-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
131I-IPA and Concurrent XRT in Recurrent GBM
Sponsor:
Telix Pharmaceuticals (Innovations) Pty Limited
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
131I-IPA-TLX-101-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None